Search Results - "Zadjura, Lisa"
-
1
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects
Published in Journal of medicinal chemistry (10-12-2009)“…Azaindole derivatives derived from the screening lead 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (1) were prepared and characterized to…”
Get full text
Journal Article -
2
A Small Molecule HIV-1 Inhibitor That Targets the HIV-1 Envelope and Inhibits CD4 Receptor Binding
Published in Proceedings of the National Academy of Sciences - PNAS (16-09-2003)“…BMS-378806 is a recently discovered small molecule HIV-1 inhibitor that blocks viral entrance to cells. The compound exhibits potent inhibitory activity…”
Get full text
Journal Article -
3
Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents
Published in Bioorganic & medicinal chemistry letters (01-01-2013)“…Optimization of the early lead compound 1 with various carboxamide substitution at the C7 position provided heteroaryl carboxamide analogs (e.g., 35) that…”
Get full text
Journal Article -
4
Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions
Published in Journal of medicinal chemistry (25-09-2003)“…Indole derivative 1 interferes with the interaction of the HIV surface protein gp120 with the host cell receptor CD4. The 4-fluoro derivative 2 exhibited…”
Get full text
Journal Article -
5
Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors
Published in Bioorganic & medicinal chemistry letters (01-01-2013)“…Optimization of the early lead compound 2 with heteroaryl substitution at the C7 position identified inhibitors with picomolar inhibitory activity. These…”
Get full text
Journal Article -
6
Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives
Published in Bioorganic & medicinal chemistry letters (01-09-2009)“…4-Fluoro- and 4-methoxy-1-(4-benzoylpiperazin-1-yl)-2-(1 H-indol-3-yl)ethane-1,2-dione ( 2 and 3, respectively) have been characterized as potent inhibitors of…”
Get full text
Journal Article -
7
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns
Published in Bioorganic & medicinal chemistry letters (01-04-2009)“…The effects of introducing simple halogen, alkyl, and alkoxy substituents to the 4, 5, 6 and 7 positions of…”
Get full text
Journal Article -
8
Orally Active Fusion Inhibitor of Respiratory Syncytial Virus
Published in Antimicrobial Agents and Chemotherapy (01-02-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
9
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties
Published in Journal of pharmaceutical sciences (01-04-2010)“…Optimizing pharmacokinetic properties to improve oral exposure is a common theme in modern drug discovery. In the present work, in vitro Caco-2 permeability…”
Get more information
Journal Article -
10
Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection
Published in Antimicrobial Agents and Chemotherapy (01-07-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
11
Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative
Published in Bioorganic & medicinal chemistry letters (01-01-2013)“…N-Acetoxymethyl 4, N-pivaloyloxymethyl 5, and N-methyl 6 were evaluated as potential oral prodrugs of the parent tetrazole 3 in rats. Prodrug 5 was ineffective…”
Get full text
Journal Article -
12
Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo
Published in Bioorganic & medicinal chemistry letters (15-08-2009)“…A series of bezimidazole-isatin oximes were prepared and profiled as inhibitors of respiratory syncytial virus (RSV) replication in cell culture…”
Get full text
Journal Article -
13
Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
Published in Bioorganic & medicinal chemistry letters (15-02-2007)“…A series of benzimidazole-based inhibitors of respiratory syncytial virus (RSV) fusion were optimized for antiviral potency, membrane permeability and…”
Get full text
Journal Article -
14
Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety
Published in Bioorganic & medicinal chemistry letters (01-09-2007)“…The effect of structural variation of the benzimidazol-2-one ring of RSV fusion inhibitors related to BMS-433771 ( 1) was examined in conjunction with side…”
Get full text
Journal Article -
15
Corrigendum to “Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives” [Bioorg. Med. Chem. Lett. 19 (2009) 5140]
Published in Bioorganic & medicinal chemistry letters (15-02-2010)Get full text
Journal Article -
16
-
17
Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics
Published in Biopharmaceutics & drug disposition (01-12-2005)“…BMS‐378806 is a prototype of novel HIV attachment inhibitors that block the gp120 and CD4 interaction, the first step of HIV‐1 entry into cells. The present…”
Get full text
Journal Article -
18
-
19
Orally active fusion inhibitor of respiratory syncytial virus
Published in Antimicrobial agents and chemotherapy (2004)Get full text
Journal Article -
20